Albertsons Companies has seen its enterprise value-to-EBITDA multiple compress to the bottom decile of its five-year range, even as management continues to exceed consensus profit forecasts. In Q3 2026, adjusted EBITDA grew by 7.8% year-over-year to $1.12 billion, surpassing the $1.05 billion analysts had modeled. Free cash flow generation of $450 million for the first nine months of fiscal 2026 has enabled the company to reduce net debt by $300 million over that period, and insider filings show share repurchases of $120 million in November. At the same time, open interest in call options on ACI has risen 35% since October, suggesting growing speculative positioning that could underpin a mean-reversion rally if broader market sentiment turns positive.

In the quarter ended November 2025, Albertsons reported a 5.2% same-store sales increase versus Q3 2024, driven by strength in private-label grocery and pharmacy categories. However, gross margin contracted by 90 basis points as the company absorbed higher inbound transportation costs and invested in temporary price reductions to fend off discounters. SG&A expenses rose to 21.4% of sales, up from 20.8% in the prior year, as the retailer poured resources into digital fulfillment and expanded its self-checkout network by 150 new units. Even with an earnings-per-share beat of $0.45 versus consensus $0.42, the stock dipped 6% in the two trading days following the release, reflecting investor concern over margin headwinds and the pace of incremental investments.